Loss of the transforming growth factor‐β effector β2‐Spectrin promotes genomic instability

Exposure to genotoxins such as ethanol‐derived acetaldehyde leads to DNA damage and liver injury and promotes the development of cancer. We report here a major role for the transforming growth factor β/mothers against decapentaplegic homolog 3 adaptor β2‐Spectrin (β2SP, gene Sptbn1) in maintaining genomic stability following alcohol‐induced DNA damage. β2SP supports DNA repair through β2SP‐dependent activation of Fanconi anemia complementation group D2 (Fancd2), a core component of the Fanconi anemia complex. Loss of β2SP leads to decreased Fancd2 levels and sensitizes β2SP mutants to DNA damage by ethanol treatment, leading to phenotypes that closely resemble those observed in animals lacking both aldehyde dehydrogenase 2 and Fancd2 and resemble human fetal alcohol syndrome. Sptbn1‐deficient cells are hypersensitive to DNA crosslinking agents and have defective DNA double‐strand break repair that is rescued by ectopic Fancd2 expression. Moreover, Fancd2 transcription in response to DNA damage/transforming growth factor β stimulation is regulated by the β2SP/mothers against decapentaplegic homolog 3 complex. Conclusion: Dysfunctional transforming growth factor β/β2SP signaling impacts the processing of genotoxic metabolites by altering the Fanconi anemia DNA repair pathway. (Hepatology 2017;65:678‐693)

[1]  Nina M. Muñoz,et al.  TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. , 2016, The Journal of clinical investigation.

[2]  Y. Gusev,et al.  βII‐Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin , 2015, Hepatology.

[3]  N. de Wind,et al.  Maternal Aldehyde Elimination during Pregnancy Preserves the Fetal Genome , 2014, Molecular cell.

[4]  Jean S. Campbell,et al.  Liver regeneration. , 2012, Journal of hepatology.

[5]  A. D’Andrea,et al.  To the rescue: the Fanconi anemia genome stability pathway salvages replication forks. , 2012, Cancer cell.

[6]  S. Elledge,et al.  Structure of the FANCI-FANCD2 Complex: Insights into the Fanconi Anemia DNA Repair Pathway , 2011, Science.

[7]  K. J. Patel,et al.  Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice , 2011, Nature.

[8]  Stephen C. West,et al.  DNA interstrand crosslink repair and cancer , 2011, Nature Reviews Cancer.

[9]  Randy L. Johnson,et al.  Loss of transforming growth factor β adaptor protein β‐2 spectrin leads to delayed liver regeneration in mice , 2011, Hepatology.

[10]  C. Deng,et al.  Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. , 2009, The Journal of clinical investigation.

[11]  G. Peng,et al.  BRIT1/MCPH1 Links Chromatin Remodeling to DNA Damage Response , 2009, Nature Cell Biology.

[12]  C. Deng,et al.  Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling , 2008, Proceedings of the National Academy of Sciences.

[13]  A. Rashid,et al.  Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation , 2007, Oncogene.

[14]  F. Stickel,et al.  “Allgemeine und systematische Pharmakologie und Toxikologie” WS 18/19 Seminarthema: Chemische Kanzerogenese , 2017 .

[15]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[16]  Zhao-Qi Wang,et al.  Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Chodosh,et al.  Conditional Overexpression of Active Transforming Growth Factor β1 In vivo Accelerates Metastases of Transgenic Mammary Tumors , 2004, Cancer Research.

[18]  W. Lambert,et al.  Nonerythroid αII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links , 2003, Journal of Cell Science.

[19]  C. Deng,et al.  Disruption of Transforming Growth Factor-β Signaling in ELF β-Spectrin-Deficient Mice , 2003, Science.

[20]  Mary Helen Barcellos-Hoff,et al.  Transforming growth factor-beta1 mediates cellular response to DNA damage in situ. , 2002, Cancer research.

[21]  S. Thorgeirsson,et al.  Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. , 2001, Cancer research.

[22]  P. Schirmacher,et al.  Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis , 2001, Oncogene.

[23]  S. Grant,et al.  Proteomic analysis of NMDA receptor–adhesion protein signaling complexes , 2000, Nature Neuroscience.

[24]  E. Bottinger,et al.  Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Thompson,et al.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. , 1999, Genes & development.

[26]  C. McKerlie,et al.  Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia , 1996, Nature Genetics.

[27]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[28]  M. Sasaki,et al.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. , 1973, Cancer research.

[29]  V. Vasiliou,et al.  The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis. , 2015, Advances in experimental medicine and biology.

[30]  V. Bennett,et al.  Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. , 2008, Trends in molecular medicine.

[31]  A. Rashid,et al.  Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. , 2007, Oncogene.

[32]  D. Weinstock,et al.  Assaying double-strand break repair pathway choice in mammalian cells using a targeted endonuclease or the RAG recombinase. , 2006, Methods in enzymology.

[33]  S. Gautam,et al.  Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. , 2005, Oncogene.

[34]  C. Deng,et al.  Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. , 2003, Science.

[35]  H. Moses,et al.  TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. , 1990, Cell.